eTheRNA products
eTheRNA - mRNA Platform
Our mRNA platforms and vast in-house experience help partners quickly optimize, screen and select an mRNA code, develop a candidate, and ensure effective & prime manufacturing of the mRNA from research grade to GMP scale. Our platform’s scale and flexibility is uniquely suited to respond to the needs of development partners across a wide range of therapeutic applications.
LNP Platforms
eTheRNA - Model IV-cLP1 - LNP Platforms
Therapeutic area: cancer vaccines; Systemic, intravenous (IV) administration
eTheRNA - Model ITu-LNP - LNP Platforms
Therapeutic area: immuno-oncology; Intra-tumoral (IT) administration.
eTheRNA - Model Im-LNPX - LNP Platforms
Therapeutic area: prophylactic vaccines; Intramuscular (IM) administration
eTheRNA - Model IV-cLNP2 - LNP Platforms
Therapeutic area: auto-immune diseases; Induction of immune tolerance against auto-antigen
eTheRNA - Model IV-cLNP3 - LNP Platforms
Therapeutic area: liver diseases, secreted factors; High expression in liver after intravenous administration
